Clinical Trials on Diabetes Mellitus, Hypercholessterolemia

Total 21220 results

JW Pharmaceutical

Completed

Efficacy and Safety Study of Pitavastatin Compared to atoRvastatin in Type 2 dIabeTes Mellitus With Hypercholesterolemia (ESPRIT)

Hypercholesterolemia With Type2DM
Yuhan Corporation
Linical Korea

Completed

A Study to Compare Rosuvastatin/Ezetimibe and Rosuvastatin in Patients With Diabetes Mellitus and Hypercholesterolemia

Diabetes Mellitus and Hypercholesterolemia

Korea, Republic of
Listen Trial Group

Completed

LIpid Lowering With Highly Potent Statins in Hyperlipidaemia With Type 2 Diabetes patiENts (LISTEN)

Hypercholesterolemia With Concomitant Type 2 Diabetes

Japan
The Catholic University of Korea
Pfizer

Unknown

Korean AMADEUS Study

Diabetes Mellitus, Hypercholessterolemia

Korea, Republic of
School of Medicine. National University of Cuyo

Recruiting

Argentine Registry of Lp(a) (GAELpa)

Cardiovascular Diseases | Hypertension | Hypercholesterolemia | Diabete Type 2 | Lp(A)

Argentina
Medical College of Wisconsin

Completed

Effect of Diabetes Mellitus on Cholesterol Metabolism

Type 2 Diabetes Mellitus | Hypercholesterolemia | Type 1 Diabetes Mellitus

United States
Organon and Co

Completed

A Multicenter Study to Evaluate the Cholesterol Lowering Effects of Two Marketed Products in Patients With Type 2 Diabetes Mellitus and Hypercholesterolemia (MK-0653A-077)

Type 2 Diabetes Mellitus | Hypercholesterolemia
Yuhan Corporation

Completed

Rosuvastatin/Ezetimibe vs Rosuvastatin in Korean Patients With Type 2 Diabetes Mellitus and Hypercholesterolemia

Type 2 Diabetes Mellitus | Hypercholesterolemia

Korea, Republic of
University of Roma La Sapienza

Unknown

Atorvastatin, Aspirin, Oxidative Stress, Coagulation and Platelet Activation Indexes

Type 2 Diabetes Mellitus | Hypercholesterolemia

Italy
University Hospital Freiburg
Essex Pharma GmbH

Completed

Effect of Ezetimibe or Simvastatin or Both on Low Densitiy Lipoprotein -Subfractions in Patients With Type 2 Diabetes (EZE)

Hypercholesterolemia | Diabetes Mellitus Type 2

Germany
Nang Kuang Pharmaceutical Co., Ltd.
National Taiwan University Hospital

Terminated

Evaluating the Efficacy and Safety of Dehypotin® in the Patients With Type 2 Diabetes Mellitus or Cardiovascular Disease

Cardiovascular Disease | Type 2 Diabetes Mellitus | Hypercholesterolemia

Taiwan
University Health Network, Toronto
The Canadian College of Naturopathic Medicine

Unknown

The Anti-Diabetic and Cholesterol-Lowering Effects of Cinnamon and Cassia Bark

Type 2 Diabetes | Hypercholesterolemia

Canada
Daiichi Sankyo, Inc.

Completed

Effects of Metformin Hydrochloride (HCl) in Combination With Colesevelam HCl, Compared to Metformin HCl Alone, in Patients With Type 2 Diabetes Mellitus and the Effects of Colesevelam HCl on Lipids and Glucose on Pre-diabetic Patients.

Type 2 Diabetes Mellitus | Hypercholesterolemia | Pre-diabetes

United States, Colombia, India, Mexico
Mayo Clinic

Completed

Effect of a Decision Aid About Statin Use in Patients With Type 2 Diabetes Mellitus

Cardiovascular Disease | Diabetes Mellitus | Dyslipidemia | Hypercholesterolemia

United States
Chinese Academy of Sciences

Completed

The Potential Effects and Mechanisms of Flax Lignans on Type 2 Diabetes Mellitus

Type 2 Diabetes | Hypercholesterolemia

China
Vanderbilt University
United States Surgical Corporation

Completed

Omentectomy for the Treatment of Diabetes Mellitus Type 2

Obesity | Dyslipidemia | Hypercholesterolemia | Diabetes Mellitus Type 2

United States
Nemours Children's Clinic
Pfizer; Medtronic; Quest Diagnostics-Nichols Insitute

Completed

Statins in Children With Type 1 Diabetes and Hypercholesterolemia

Hypercholesterolemia | Diabetes Mellitus, Insulin-Dependent

United States
Inje University
Kuhnil Pharmaceutical Co., Ltd.

Unknown

The Effects of Omega-3 Fatty Acid (OMACOR) on the Low-density Lipoprotein (LDL) Sub-fraction in Type 2 Diabetic Patients

Diabetes Mellitus, Type 2 | Hypercholesterolemia | Hypertriglyceridemia

Korea, Republic of
Amsterdam UMC, location VUmc
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Completed

Dapagliflozin and Cholesterol Metabolism in Type 2 Diabetes (DM2) (DICE)

Diabetes Mellitus, Type 2 | Hypercholesterolemia

Netherlands
Amgen

Completed

Evaluation of Evolocumab (AMG 145) Efficacy in Diabetic Adults With Hypercholesterolemia/Mixed Dyslipidemia (BANTING)

Type 2 Diabetes | Hypercholesterolemia | Mixed Dyslipidemia

United States, Italy, Belgium, Spain, Canada, Poland, Mexico
Kinderkrankenhaus auf der Bult

Completed

Pediatric Population Screening for Type 1 Diabetes and Familial Hypercholesterolemia in Lower Saxony, Germany (Fr1dolin)

Type 1 Diabetes | Familial Hypercholesterolemia
Sanofi
Regeneron Pharmaceuticals

Completed

Usability Study of the Commercial Auto-injector Device and the New Auto-injector Device (SYDNEY) in Patients With High or Very High CV Risk With Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy

Hypercholesterolaemia

United States
GlaxoSmithKline

Completed

Acotral® Versus Zetia® Ezetimibe Bioequivalance Study.

Hypercholesterolaemia

India
AstraZeneca

Completed

Registry On Efficacy and Safety Of Rosuvastatin, and Atorvastatin and Simvastatin In Hypercholesterolaemia

Hypercholesterolaemia

Singapore
AstraZeneca

Completed

PULSAR - A Prospective Study to Evaluate the Utility of Low Doses of the Statins Atorvastatin and Rosuvastatin.

Hypercholesterolaemia
Unilever R&D
Commonwealth Scientific and Industrial Research Organisation, Australia

Completed

The Effect of Plant Sterols on the Blood Lipid Profile of Subjects With and at High Risk of Type 2 Diabetes Mellitus

Vascular Diseases | Diabetes Mellitus | Hypercholesterolemia

Australia
Mount Sinai Hospital, Canada
University of Manitoba; Women's College Hospital

Recruiting

Time Spent In Target Glucose Range in Women With T2D Diabetes in Pregnancy (Timely)

Pregnancy in Diabetic | Diabete Type 2

Canada
Akeso
AD Pharmaceuticals Co., Ltd.

Completed

A Study of PCSK9 Inhibitor AK102 in Healthy Subjects

Hypercholesterolaemia

China
GlaxoSmithKline

Completed

Rosuvastatin Calcium Bioequivalence Study - Fast

Hypercholesterolaemia

Brazil
AstraZeneca

Completed

Evaluation of Patients Treated With HMG-CoA Reductase Inhibitors to Reach Cholesterol Target Values

Hypercholesterolaemia

Bosnia and Herzegovina
AstraZeneca

Completed

Non-interventional Study (NIS) to Assess Reaching of Cholesterol Target Values in Patients Treated With HMG-CoA Reductase Inhibitors

Hypercholesterolaemia

Croatia
AstraZeneca

Completed

Rosuvastatin Efficacy and Safety Evaluation in Hypercholesterolaemic Patients (RESEARCH)

Hypercholesterolaemia

Greece
AstraZeneca

Completed

OLE Study to Evaluate Safety / Efficacy of ZD4522

Hypercholesterolaemia
Positive Trial Group

Terminated

Primary Prevention of Major Adverse Cardiac Events (MACE) With Standard and Intensive Statin Treatment in Patients With Diabetes: Survival and Cardiovascular Event Assessments (POSITIVE)

Hypertension | Type 2 Diabetes | Hypercholesterolemia

Japan
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Carotid Atorvastatin Study in Hyperlipidemic Post-Menopausal Women

Hypercholesterolaemia

France, Belgium, Netherlands
AstraZeneca

Terminated

Study of Asian Patients With Hypercholesterolaemia in the UK - Rosuvastatin 5mg Versus Atorvastatin 10mg

Hypercholesterolaemia

United Kingdom
Novartis Pharmaceuticals

Recruiting

Specified Drug-use Survey of Leqvio for s.c. Injection.

Hypercholesterolaemia | Familial Hypercholesterolaemia

Japan
University of Saskatchewan
Saskatchewan Health Research Foundation

Completed

Single Oral Dose of BeneFlax to Healthy Young and Older Adults (SOD)

Diabetes Mellitus, Type 2 | Hypercholesterolemia

Canada
Amgen

Terminated

Study to Evaluate the Safety of Repatha® in Pregnancy

Pregnancy | Hypercholesterolaemia

Belgium, Denmark, Italy, Czechia, United Kingdom, Australia, Austria, Greece, Switzerland, Netherlands, Spain, Sweden, Slovakia, Norway
AstraZeneca

Withdrawn

ORBITAL: Open-Label Primary Care Study: Rosuvastatin Based Compliance Initiatives Linked To Achievement Of LDL Goals

Primary Hypercholesterolaemia
AstraZeneca

Completed

Centralized Pan-South African Survey on the Undertreatment of Hypercholesterolaemia (CEPHEUS)

Undertreatment of Hypercholesterolaemia

South Africa
Zhongshan Ophthalmic Center, Sun Yat-sen University

Unknown

Multi-modal Imaging and Artificial Intelligence Diagnostic System for Multi-level Clinical Application

Diabetic Retinopathy | Diabete Mellitus

China
Amgen

Completed

Chart Review of Repatha® in Subjects With Hyperlipidaemia (HEYMANS)

Hypercholesterolaemia

Austria, Italy, Belgium, Czechia, Switzerland, Spain, Slovakia, Germany, Portugal, Greece, Bulgaria, Sweden
Novo Nordisk A/S

Completed

A Research Study Investigating How NNC0385-0434 is Tolerated in People With or Without High Cholesterol Levels

Healthy Volunteers | Hypercholesterolaemia

United Kingdom
Organon and Co

Completed

TWICE (Ezetimibe Together With Any Statin Cholesterol Enhancement)(0653-060)

Hypercholesterolaemia | Hyperlipidaemia
Danone Research

Completed

Pilot Study in the Cholesterol Absorption Reduction After Consumption of Low-fat, Drinkable Fermented Milk Enriched With Plant Sterols

Mildly Hypercholesterolemic Subjects

Canada
Danone Research

Completed

Effects of Fermented Milk Product Enriched With Plant Sterols and Policosanols in Mild Hypercholesterolaemic Adults

Mildly Hypercholesterolemic Subjects

United Kingdom
Danone Research

Completed

Effect of the Consumption of a Fermented Milk Enriched With Plant Sterols (Italy)

Mildly Hypercholesterolemic Subjects

Italy
Oguzhan Kahveci

Recruiting

Examination of the Effects of Chromium Levels on Glucose Metabolism, Lipid Metabolism, Morbidity and Mortality Rates in Patients Followed in Intensive Care Unit

Diabetes Mellitus | Hypercholesterolemia | Hyperlipidemias | Chromium Deficiency

Turkey
Association for Innovation and Biomedical Research...

Completed

Prospective, Randomized, Open Label, Phase II Study to Assess Efficacy and Safety of Macugen® (Pegaptanib 0.3 mg Intravitreal Injections) Plus Panretinal Photocoagulation and PRP (Monotherapy) in the Treatment With High Risk PDR.

Diabetes Mellitus Type II | Diabetes Mellitus Type I | High Risk Proliferative Diabetic Retinopathy

Portugal

Clinical Trials on Diabetes Mellitus, Hypercholessterolemia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mali

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations